Sionna Therapeutics, Inc.(SION)
$2.970.00 (0.00%)
SION
Sionna Therapeutics, Inc. financials statements
$2.97
At close:0.00 (0.00%)
Want to see SION full AI Analyst Report?
Sionna Therapeutics, Inc. (SION) Ratios
71 Followers
Sionna Therapeutics, Inc. Ratios
SION's free cash flow for Q3 2026 was $-18.72M. For the 2026 fiscal year, SION's free cash flow was increased by $0.00 and operating cash flow was $-18.72M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 20.61 | 14.49 | 4.88 | 10.16 |
| Quick Ratio | 20.61 | 14.49 | 4.88 | 10.16 |
| Cash Ratio | 4.99 | 3.63 | 4.79 | 6.64 |
| Solvency Ratio | -3.90 | -0.17 | -0.28 | -0.26 |
| Operating Cash Flow Ratio | -5.66 | -5.07 | -5.44 | -4.37 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 222.30M | $ -198.47M | $ -127.62M | $ -73.46M |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 0.03 | 0.05 | 0.20 | 0.00 |
| Debt-to-Equity Ratio | 0.03 | -0.06 | -0.09 | 0.00 |
| Debt-to-Capital Ratio | 0.03 | -0.06 | -0.10 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.06 | -1.13 | -0.45 | -1.25 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.22 | 0.22 | 0.24 | 0.00 |
| Net Debt to EBITDA | 0.67 | 0.46 | 0.56 | 1.33 |
| Profitability Margins | ||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 84.59% | 87.43% | 93.90% | 97.26% |
| Return on Assets (ROA) | -23.09% | -33.21% | -90.99% | -46.06% |
| Return on Equity (ROE) | -24.53% | 37.68% | 41.14% | 57.55% |
| Return on Capital Employed (ROCE) | -28.32% | -40.24% | -114.63% | -52.29% |
| Return on Invested Capital (ROIC) | -28.20% | -40.00% | -112.76% | -52.29% |
| Return on Tangible Assets | -23.09% | -33.21% | -90.99% | -46.06% |
| Earnings Yield | -4.58% | -5.59% | -4.28% | -3.65% |
| Efficiency Ratios | ||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.84 | 0.56 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -433.83 | -648.04 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 433.83 | 648.04 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | -1.66 | -1.20 | -0.99 | -0.82 |
| Free Cash Flow Per Share | -1.67 | -1.20 | -1.02 | -0.86 |
| Dividend Paid and CapEx Coverage Ratio | -175.85 | -1955.07 | -39.16 | -19.25 |
| Capital Expenditure Coverage Ratio | -175.85 | -1955.07 | -39.16 | -19.25 |
| Operating Cash Flow Coverage Ratio | -7.64 | -5.41 | -4.17 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -4.06% | -4.79% | -4.06% | -3.44% |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | -21.88 | -17.86 | -23.34 | -27.41 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 5.36 | -6.74 | -9.60 | -15.78 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -24.66 | -20.89 | -24.61 | -29.07 |
| Price-to-Operating Cash Flow Ratio | -24.80 | -20.90 | -25.24 | -30.58 |
| Price-to-Earnings Growth (PEG) Ratio | -0.64 | -0.58 | -1.34 | 0.00 |
| Enterprise Value Multiple | -21.36 | -17.62 | -21.61 | -25.41 |
| Enterprise Value | 1.59B | 1.08B | 1.08B | 1.05B |
| EV to EBITDA | -21.36 | -17.62 | -21.61 | -25.41 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -23.91 | -20.36 | -23.99 | -27.63 |
| EV to Operating Cash Flow | -24.05 | -20.37 | -24.60 | -29.06 |
| Tangible Book Value Per Share | 7.68 | -3.71 | -2.60 | -1.58 |
| Shareholders’ Equity Per Share | 7.68 | -3.71 | -2.60 | -1.58 |
| Tax and Other Ratios | ||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -1.88 | -1.40 | -1.07 | -0.91 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 0.94 | 0.97 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.88 | 0.86 | 0.92 | 0.90 |
Currency in USD

